|
84 Companies |
|
139 Products |
|
139 Products |
|
62 Mechanisms of Action |
|
7 Trials |
|
632 News |
|
| «12...234567891011121314» |
- | cyclophosphamide / Generic mfg.
Trial completion, Pre-transplantation: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P3, N=83, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Zarnestra (tipifarnib) / Kura Oncology
Trial completion, Metastases: Tipifarnib in Treating Patients With Advanced Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=36, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Suspended --> Completed
- | topotecan / Generic mfg.
Trial completion: Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (clinicaltrials.gov) - Feb 19, 2014
P2, N=77, Completed, Sponsor: National Cancer Institute (NCI)
Suspended --> Completed Recruiting --> Completed
- | cyclophosphamide / Generic mfg.
Trial completion: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Recruiting --> Completed Active, not recruiting --> Completed
- | azacitidine / Generic mfg., sodium phenylbutyrate / Generic mfg.
Trial completion, Combination therapy, Metastases: Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Sidney Kimmel Comprehensive Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Zolinza (vorinostat) / Merck (MSD)
Trial completion, Metastases: Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=7, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | topotecan / Generic mfg., carboplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Combination therapy: Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=17, Completed, Sponsor: Fox Chase Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, peripheral blood stem cell transplantation / National Cancer Institute
Trial completion, Post-transplantation: Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Northwestern University
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | cyclophosphamide / Generic mfg.
Trial completion: Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=6, Completed, Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | tanespimycin (BMS-722782) / BMS
Trial completion, Metastases: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, peripheral blood stem cell transplantation / National Cancer Institute
Trial completion: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Northwestern University
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | captopril / Generic mfg.
Trial completion: Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=35, Completed, Sponsor: Northwestern University
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases: Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=40, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, Neumega (oprelvekin) / Astellas
Trial completion: Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | LymphoCide Y-90 (epratuzumab Y-90) / Gilead, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=18, Completed, Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Emcyt (estramustine) / Pfizer, Nippon Shinyaku
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | LymphoCide Y-90 (epratuzumab Y-90) / Gilead
Trial completion: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=21, Completed, Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tanespimycin (BMS-722782) / BMS
Trial completion, Surgery: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Suspended --> Completed
- | Kepivance (palifermin) / SOBI, Amgen, Neupogen (filgrastim) / Kyowa Kirin, Amgen, peripheral blood stem cell transplantation / National Cancer Institute
Trial completion: Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=111, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Suspended --> Completed Active, not recruiting --> Completed
- | bortezomib / Generic mfg.
Trial completion, Metastases: PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | irinotecan / Generic mfg.
Trial completion: Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=60, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | Zokinvy (lonafarnib) / Eiger
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=25, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease (clinicaltrials.gov) - Feb 19, 2014
P2, N=390, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | fluconazole oral / Generic mfg., itraconazole / Generic mfg.
Trial completion: Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation (clinicaltrials.gov) - Feb 19, 2014
P3, N=578, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | melphalan / Generic mfg., busulfan / Generic mfg., cyclosporine / Generic mfg.
Trial completion: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=3, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Rituxan (rituximab) / Roche
Trial completion: Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=120, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=38, Completed, Sponsor: Eastern Cooperative Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | irinotecan / Generic mfg.
Trial completion: Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | topotecan / Generic mfg., 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=30, Completed, Sponsor: New York University School of Medicine
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion, Metastases: Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=24, Completed, Sponsor: Roswell Park Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=20, Completed, Sponsor: Scripps Health
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | irinotecan / Generic mfg.
Trial completion: Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=50, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed No longer recruiting --> Completed
- | vincristine / Generic mfg.
Trial completion: Bryostatin and Vincristine in B-Cell Malignancies (clinicaltrials.gov) - Feb 19, 2014
P1, N=18, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | cyclophosphamide / Generic mfg., busulfan / Generic mfg.
Trial completion: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=66, Completed, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=27, Completed, Sponsor: University of Arizona
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | decitabine / Generic mfg.
Trial completion, Metastases: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: California Cancer Consortium
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | sodium phenylbutyrate / Generic mfg.
Trial completion: Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=24, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | Trial completion: Perillyl Alcohol in Treating Patients With Refractory Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=25, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | phenobarbital / Generic mfg., cyclosporin A microemulsion / Generic mfg., irinotecan / Generic mfg.
Trial completion: Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P1, N=3, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Not yet recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=25, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation (clinicaltrials.gov) - Feb 19, 2014
P2, N=30, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap, Neupogen (filgrastim) / Kyowa Kirin, Amgen
Trial completion: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Temple University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Proleukin (aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Trial completion, Metastases: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Hoag Memorial Hospital Presbyterian
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Recentin (cediranib) / AstraZeneca, Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (clinicaltrials.gov) - Feb 13, 2014
P1, N=57, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- cyclophosphamide / Generic mfg.
Trial initiation date: Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 9, 2014
P2, N=20, Recruiting, Sponsor: National University Health System, Singapore
Active, not recruiting --> Completed Initiation date: Sep 2013 --> Jan 2014